# Test of Novel Drug for Smoking Cessation

> **NCT02217527** · PHASE2 · COMPLETED · sponsor: **Chengappa, K.N. Roy, MD** · enrollment: 36 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Active JNJ Drug
- **DRUG:** Placebo pill

## Key facts

- **NCT ID:** NCT02217527
- **Lead sponsor:** Chengappa, K.N. Roy, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2017-07
- **Final completion:** 2018-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02217527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02217527, "Test of Novel Drug for Smoking Cessation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02217527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*